chatgpt
-
Why Boards Often Realise the Value of a CMO Too Late
Clinical leadership in MedTech is rarely treated as a strategic variable at the start. In early stages, it often appears procedural. A role associated with compliance, trials, and regulatory navigation. Certainly treated as important but not always central to valuation. That perception tends to change when the inevitable pressure mounts. As scale approaches, clinical judgement…
-
The Gap Between How AI Is Built and How It Will Be Assessed
Most AI MedTech companies are doing the right things, just in a way regulators will not recognise. Internally, everything feels controlled; externally, it will be judged by a very different standard. That gap widens fastest in companies moving quickly, led by capable teams who assume alignment will catch up later. But it rarely does. How…
Harun Rabbani 